Background-The transcription factor NKX2-5 is crucial for heart development, and mutations in this gene have been implicated in diverse congenital heart diseases and conduction defects in mouse models and humans. Whether NKX2-5 mutations have a role in adult-onset heart disease is unknown. Methods and Results-Mutation screening was performed in 220 probands with adult-onset dilated cardiomyopathy. Six NKX2-5 coding sequence variants were identified, including 3 nonsynonymous variants. A novel heterozygous mutation, I184M, located within the NKX2-5 homeodomain, was identified in 1 family. A subset of family members had congenital heart disease, but there was an unexpectedly high prevalence of dilated cardiomyopathy. Functional analysis of I184M in vitro demonstrated a striking increase in protein expression when transfected into COS-7 cells or HL-1 cardiomyocytes because of reduced degradation by the Ubiquitin-proteasome system. In functional assays, DNA-binding activity of I184M was reduced, resulting in impaired activation of target genes despite increased expression levels of mutant protein. Conclusions-Certain NKX2-5 homeodomain mutations show abnormal protein degradation via the Ubiquitin-proteasome system and partially impaired transcriptional activity. We propose that this class of mutation can impair heart development and mature heart function and contribute to NKX2-5-related cardiomyopathies with graded severity. 
D ilated cardiomyopathy (DCM) is a major cause of morbidity and mortality. Significant progress toward new management strategies for DCM is critically dependent on a better understanding of disease pathophysiology. Over the past decade, it has been recognized that inherited genetic factors are causative of DCM in a substantial proportion of cases, and >40 chromosomal loci and disease genes have been identified to date. 1 Functional characterization of these genetic variants indicates that diverse cardiomyocyte structural and signaling defects can result in the DCM phenotype. 2 
Clinical Perspective on p 247
The homeobox transcription factor NKX2-5 is expressed in cardiac precursor cells from Drosophila to humans and is essential for heart development and determination of myocardial cell fate. 3, 4 Absence of NKX2-5 in mice results in impaired cardiac growth and chamber formation, deranged gene regulatory network, and early embryonic lethality. 5, 6 Heterozygous and conditional deletion at postnatal stages has shown that NKX2-5 activity is also essential for maintenance of the cardiac conduction system. [7] [8] [9] Mutations in the human NKX2-5 gene have been associated with a diverse range of congenital heart disease (CHD) and conduction defect (CD) phenotypes, including atrial and ventricular septal defects, atrioventricular conduction block, tetralogy of Fallot, hypoplastic left heart, transposition of the great arteries, dextracardia and valvular malformations, [10] [11] [12] [13] [14] and overexpression of NKX2-5 underpins CDs in myotonic dystrophy, a toxic RNA disease. 15 In addition to its role in early cardiac morphogenesis, studies in Drosophila and mice suggest that NKX2-5 and its transcriptional cofactors are critical determinants of later ventricular myocyte maturation and adult heart function. 7, [16] [17] [18] In families with CHD-causing NKX2-5 mutations, left ventricular contractile dysfunction has been observed in a few cases. 10, 14 DCM may in fact occur as a late clinical manifestation of a predominant CHD phenotype; however, the relative importance of NKX2-5 mutations as a direct cause of DCM has not been determined. DCM can be a primary manifestation of heterozygous mutations in TBX20, an NKX2-5 transcriptional cofactor, in humans and mice. 17, 19 Here, we report the results of a mutation screening study in a large cohort of individuals with adult-onset familial DCM. Detailed functional analysis of a novel NKX2-5 mutation, I184M, showed increased protein stability, in association with reduced transcriptional activation. Our findings highlight a previously unexplored role of defective Ubiquitin-mediated protein degradation in NKX2-5-related cardiac pathologies.
Methods
An expanded Methods section is available in the online-only Data Supplement.
Study Subjects
White probands with a family history of DCM were recruited from St. Vincent's Hospital (n=146) and Harvard Medical School (n=74). A supplementary group of unrelated individuals with left ventricular noncompaction (LVNC; n=24) was recruited from Royal Prince Alfred Hospital and the National Australian Childhood Cardiomyopathy Study. One hundred healthy white volunteers comprised a control group. All participants gave informed written consent, and study protocols were approved by the relevant institutional Human Research Ethics Committees.
Mutation Screening
Protein-coding sequences of the NKX2-5 gene were amplified by polymerase chain reaction from genomic DNA using primers derived from intron sequences. Amplimers were sequenced using the Big Dye terminator and were analyzed on an ABI PRISM 3700 DNA Analyzer (Applied Biosystems, Foster City, CA).
Molecular Modeling
A homology model of human NKX2-5 homeodomain was generated using x-ray crystallography data derived from NKX2-5 homeodomain complexed to DNA 20 and Insight II software (Accelyrs, San Diego, CA).
Cell Transfections
COS-7 and HL-1 cells were transfected using Lipofectamine/Plus (Invitrogen) or electroporation (NEON system, Invitrogen, Carlsbad, CA) with reporter plasmids and plasmids containing untagged and FLAG, hemagglutinin (HA), Myc-tagged point mutations at murine amino acid sites equivalent to human NKX2-5 homeodomain mutations or reported functional variants. 10, 13, 14, 21, 22 Results were expressed as fold activity after normalization for Renilla activity.
Electrophoretic Mobility Shift Assay and Glutathione S-transferase Pull-Down Analyses
Glutathione S-transferase-cleaved NKX2-5 homeodomain and in vitro-translated [ 35 S]-labeled NKX2-5 proteins (TNT Quick Coupled System, Promega, Madison, WI) were produced and electrophoretic mobility shift assay was performed as described. 23 For pull-down analysis, Glutathione S-transferase-fusion protein was incubated with in vitro-translated [ 35 S]-NKX2-5 protein, subjected to SDS-PAGE , and visualized by autoradiography.
Immunoprecipitation, In Vitro Ubiquitylation, and Western Blotting
Lysates prepared from transfected cells were subjected to coimmunoprecipitation and Western blotting according to the manufacturer's protocols. In vitro ubiquitylation studies were performed using Ubiquitin Protein Conjugation Kit (Calbiochem, Darmstadt, Germany) and in vitro-translated [S 35 ]-radiolabeled NKX2-5 proteins (Promega, Madison, WI).
Results
Evaluation of the NKX2-5 gene in 220 family probands with adult-onset DCM identified 6 coding sequence variants, including 3 nonsynonymous variants (Table 1) . One proband had an R25C change that has been associated with CHD and results in a modest deficit in NKX2-5 dimerization.
10,12,24 Although we did not detect R25C in 100 control subjects, it has been reported in other white and black control populations. 12 A second proband had an A119S change reported previously in an individual with thyroid ectopy but also in relatives with normal thyroid function and showed reduced DNA-binding affinity. 25 These data suggest that both R25C and A119S are likely to be rare, disease-modifying polymorphisms.
A novel I184M variant was found in 1 proband with DCM and CD (family DO; Figure 1A and 1B) and in all other affected family members ( Figure 1C NKX2-5 transgene with an isoleucine to proline substitution at amino acid 183, which is equivalent to codon 184 in humans, develop rapidly progressive DCM and CD during early adult life. 16 The proband DO-II-4 presented recurrent syncope and complete heart block at 46 years of age. Echocardiography showed moderate to severe DCM with apical left ventricular thickening indicative of LVNC (Table 2) . A patent foramen ovale was identified, but there was no significant CHD. His youngest son, DO-III-7, had a right bundle-branch block with a normal echocardiogram. Individuals DO-II-3 and DO-III-4 had atrial septal defects diagnosed in childhood that had required surgical repair. Neither of these individuals had experienced cardiac symptoms, but clinical screening at the time of study recruitment showed DCM and CD. Individual DO-III-1 had tricuspid atresia diagnosed shortly after birth with progressive heart failure and death by 3 years of age.
LVNC may occur in association with CHD and has been observed in some humans with NKX2-5 mutations 26 and in mice with a ventricle-restricted knockout of NKX2-5.
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LVNC was present in 3 proband in which NKX2-5 mutations were not identified. To further evaluate possible associations between NKX2-5 and LVNC, a cohort of 24 individuals with LVNC was evaluated; however, no additional mutations were found.
Predicted Structural Consequences of I184M NKX2-5
The human NKX2-5 homeodomain contains 60 amino acids and comprises 3 α-helices. I184 is located in the third helix at a position in which isoleucine is highly conserved from humans to flies (Figure 2A ). The third helix lies in close proximity to the major groove of DNA, and the region N-terminal to helix 1 is positioned along the minor groove ( Figure 2B) . Loss of the β-methyl group at I184 reduces hydrophobic contacts with neighboring amino acids and ribose rings in the DNA backbone, whereas methionine replaces a relatively compact side chain with a linear one and introduces a sulfur atom that creates electrostatic clashes with glutamine at position 187 and increases hydrogen-bonding potential with asparagine at position 188 ( Figure 2C -2E). These changes alter the orientation of neighboring side chains in the homeodomain helix, as well as their interactions with bases in the DNA backbone and would be expected to reduce NKX2-5 affinity for its target sites.
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I184M NKX2-5 Retains Interaction With Other Transcription Factors but Has Impaired Transcriptional Activity
Our modeling study suggested that I184M mutation alters functional properties of the NKX2-5 protein. Using electrophoretic mobility shift assay, we evaluated relative binding affinity of wild-type (WT) and mutant NKX2-5 proteins for the Nppa promoter, a well-known target of NKX2-5. NKX2-5 protein was produced by in vitro transcription/ translation of full-length NKX2-5 cDNA, and bacterial expression of the NKX2-5 homeodomain was confirmed by retardation of migration of the WT DNA/protein complex on addition of NKX2-5 antibody ( Figure 3A , lanes 2-4). Using full-length NKX2-5 protein, the I184M mutation showed no detectable DNA binding ( Figure 3A , lanes 5-7). Bacterially expressed WT NKX2-5 homeodomain bound to the Nppa promoter as a monomer at low protein concentrations and progressively as a dimer with increasing concentration ( Figure 3B , lanes 2-6). I184M NKX2-5 homeodomain showed only weak DNA binding to Nppa promoter and only as AF indicates atrial fibrillation; ASD, atrial septal defect; CD, conduction defect; CHB, complete heart block; CHD, congenital heart disease; DCM, dilated cardiomyopathy; NA, not applicable; PFO, patent foramen ovale; PPM, permanent pacemaker; and RBBB, right bundle-branch block.
*Age at DCM diagnosis (age at study) expressed as years.
a monomer ( Figure 3B , lanes 7-11). Comparison of monomer band intensities suggested that I184M-NKX2-5 binding is ≥10-fold less than WT NKX2-5 under these conditions. We have also analyzed the ability of I184M NKX2-5 to activate its primary target promoters using luminescence assays in COS-7 cells. I184M variant showed 2-to 3-fold reduced transcriptional activity on the Nppa promoter ( Figure 4A ). This reduction was similar in assays using both Nppa and Gja5 promoters and in which NKX2-5 acts in synergy with cofactors GATA4 and TBX20 ( Figure 4B and 4C). We further compared the transcriptional activity of I184M with 2 other variants, I184P and Y191C, which also have markedly reduced DNA-binding affinity. I184P (also affecting I184), although not found in humans to date, was previously designed as a possible dominantnegative NKX2-5 protein on the basis of activity of proline -7) . B, EMSA performed with increasing amounts of Glutathione S-transferasepurified NKX2-5 homeodomain (HD) showed that WT NKX2-5 HD (arrowheads, lanes 2-6) displayed ≥10-fold greater DNA-binding affinity than NKX2-5 I184M (lanes 7-11) .
substitutions occurring in this same amino acid in other homeodomain proteins, and when overexpressed in hearts in transgenic mice, it led to rapid onset-DCM. 16, 24 Y191C was identified in a family with CD and atrial septal defects 10 and interrupts the unique tyrosine that specifies the NK2 class of homeodomain protein and is critical for their atypical DNAbinding specificity. 3 Transcriptional activity of I184P and Y191C variants was more strongly compromised than that of I184M ( Figure 4B and 4C) . Although I184M NKX2-5 was unable to compete with WT NKX2-5 in synergy with GATA4 and TBX20 over a range of doses, both I184P and Y191C showed dominant-negative activity, with Y191C completely abrogating transcriptional activation, even at the lowest dose ( Figure 4D ). These results suggest that the I184M mutant retains partial transcriptional activity and, unlike I184P, is not a strong dominant-negative protein in vitro. 16, 24, 27 Overexpression of NKX2-5 I184M mutant in the murine atrial cardiomyocyte cell line HL-1 28 showed impaired expression of endogenous Nppa relative to the WT protein ( Figure 4E ). In this context, GATA4 and Gja1 were unaffected. These data, nonetheless, confirm the decreased functionality of the I184M mutant.
Protein-protein interactions between NKX2-5 homeodomain and its cofactors enhance transcriptional activation in vitro and likely form a critical layer of the cardiac gene regulatory network. Using a Glutathione S-transferase-fusion protein pull-down assay, no difference was found in the capacity of NKX2-5 I184M to interact with in vitro-translated cofactors GATA4, TBX5, or TBX20 or with NKX2-5 homeodomain, reflecting NKX2-5 homodimerization (Figure 4F) , suggesting that the previously observed impairment in transcriptional activity is mostly because of the inability of the mutant protein to bind DNA.
I184M NKX2-5 Protein Localization and Stability
The N-terminal region of the NKX2-5 homeodomain contains a nuclear localization signal, and several NKX2-5 mutations in this domain show aberrant nuclear localization, directly impacting on protein function. 21 We confirmed that the cellular distribution of NKX2-5 I184M mutant protein was comparable with that of WT proteins, showing diffuse nuclear localization. However, we noted that immunofluorescence detection of NKX2-5 I184M gave a more intense signal than WT NKX2-5 ( Figure 5A ). Although levels of WT and I184M mutant transcripts were similar ( Figure IA and IB in the online-only Data Supplement), there was a ≥3-fold increase in I184M protein expression by Western blotting ( Figure 5B ). As a result of this finding, we reassessed transcriptional activity of I184M after normalization of protein levels and confirmed transcriptional impairment on the Nppa and 3xhemagglutinin promoters ( Figure IC in the online-only Data Supplement). Transiently expressed NKX2-5 WT, I184M, and I184P in HL-1 cardiomyocytes also showed increased mutant protein levels, most pronounced for I184P ( Figure 5C ). Steady-state protein levels are a measure of the balance of newly synthesized protein versus degradation. Inhibition of protein biosynthesis using cycloheximide, an inhibitor of protein translation, showed that robust levels of both NKX2-5 I184M and I184P persisted >12 hours when NKX2-5 WT protein had substantially diminished, indicating increased protein stability of the mutants ( Figure 5D ). Elevated protein levels were also observed for several other NKX2-5 homeodomain mutations located between homeodomain residues 171 and 190. These mutations target helices 2 and 3, which comprise the helix-turn-helix backbone of the homeodomain fold. Higher protein levels were not seen for the Y191C mutation, which lies just to the edge of the helix-turn-helix region and, as noted, interrupts the unique tyrosine found in this position in NK2 class homeodomain proteins that is critical for their unique DNA-binding specificity ( Figure 5E) . 10, 16, 21, 24 No changes in protein levels were observed for 2 other mutations that lie outside of helices 2 and 3: S164A that destroys a casein kinase II phosphorylation site involved in transactivation, 22 and R142C, located within the nuclear localization signal. 13 The Ubiquitin-proteasome system (UPS) is the major pathway for degradation of intracellular proteins. 29 To evaluate NKX2-5 mutant protein turnover, we transiently transfected COS-7 cells with WT or I184M NKX2-5 vectors followed by treatment with the specific proteasome inhibitor Lactacystin. WT NKX2-5 showed a 3.1-fold increase in protein levels over controls on UPS inhibition (P<0.01), whereas no significant changes were observed for the NKX2-5 I184M mutant ( Figure 6A ; Figure IIA in the online-only Data Supplement). CYCLIN D1 is known to undergo proteasomal degradation, and treatment with Lactacystin led to its accumulation, thus confirming the active disruption of proteasomal activity ( Figure 6A) . The same accumulation patterns were seen when MG132, another commonly used UPS inhibitor, was administered ( Figure IIB in the online-only Data Supplement). Cotransfection of FLAG-tagged NKX2-5 and hemagglutinin-tagged Ubiquitin vectors and immunoprecipitation with FLAG antibody allowed the detection of high molecular weight Ubiquitin-linked NKX2-5 intermediates by Western blotting with hemagglutinin antibody ( Figure 6B ). NKX2-5/ Ubiquitin complexes were more prominent in the presence of MG132 ( Figure 6B, lanes 4-5) , consistent with accumulation of intermediates marked for degradation. The I184M mutant was also ubiquitylated ( Figure 6C ). In vitro-translated I184M, I184P, and Y191C mutant proteins were also ubiquitylated in vitro ( Figure 6D ). Collectively, our findings suggest that NKX2-5 levels are regulated by UPS-mediated degradation, and mutations at I184 show defective degradation. The defective accumulation of I184M occurs downstream of ubiquitylation.
NKX2-5 Transcriptional Potential and Turnover
For a subset of transcription factors, transcriptional activation is intimately linked to degradation. In such cases, Ubiquitin enzymes and proteasomal components are found within the nuclear transcriptional complex, 30, 31 and increased transcriptional activity leads to increased turnover. In transfected cells, NKX2-5 achieves maximum activity after deletion of the region C-terminal to the homeodomain, 32 which contains several conserved domains that regulate transcriptional activity. 3 To explore a potential relationship between increased NKX2-5 transcriptional activity and turnover, we assessed protein levels of NKX2-5 that were WT or I184P mutant in the homeodomain in the context of the full-length protein or a deletion of the repressive C-terminal region (NKX2-5ΔC) 32 ( Figure 7A) . Overall, the C-terminally truncated NKX2-5 seemed more stable than NKX2-5 WT, results that seem contrary to those previously published for other transcription factors. However, both NKX2-5 I184P and NKX2-5ΔC I184P were significantly more stable than their nonmutant counterparts, with NKX2-5ΔC I184P more stable than NKX2-5 I184P. Although the mechanisms remain unclear, these data suggest a complex relationship between activity and turnover in the context of I184P mutation.
It is likely that many, if not all, members of the homeodomain superfamily are regulated by the UPS. To determine whether there is a common link between mutations in helices 2 and 3 of the homeodomain and disturbed UPS-mediated degradation in divergent homeodomain proteins, we analyzed the effects of substituting proline for isoleucine/valine at position 184 in the NK2 class homeodomain protein BAPX1, whose homeodomain sequence is highly related to that of NKX2-5, in the more distantly related LIM-homeodomain protein ISLET1, and the paired homeodomain protein PAX7 ( Figure 7B ). Transfection of WT or mutant proteins into COS-7 cells showed increased stability only for members of the NK2 class, NKX2-5 and BAPX1, but not for ISLET 1 or PAX7, despite all proteins being substrates for ubiquitylation in vitro ( Figure 7C and 7D) . Thus, the increased stability seen for I184P and other helix 2-helix 3 homeodomain mutations in NKX2-5 does not reflect a universal feature of the ancient homeodomain fold.
Discussion
Here, we report the identification and functional analysis of a novel NKX2-5 mutation, I184M, causative for CHD and CD but also associated with an unusually high prevalence of familial adult-onset DCM. The I184M NKX2-5 protein had significantly reduced DNA binding and transcriptional activity, and it accumulated in the nuclear compartment of transfected cells because of defective UPS-mediated degradation. NKX2-5 accumulation was also seen for several other human helix 2 and 3 NKX2-5 homeodomain mutations, and our studies on the NKX2-5ΔC mutation support a link between activation and degradation of NK2 class homeodomain transcription factors. Differences in the degree of protein accumulation between I184M and I184P, and in their transcriptional and dominant-negative effects, suggest a graded severity in these features that likely affect phenotypic outcome. We hypothesize that certain homeodomain mutations leading to accumulation of protein can be causative for adult-onset DCM with graded severity.
NKX2-5 Homeodomain Mutations Reduce DNA Binding and Transcriptional Activation
Most CHD-causing mutations in NKX2-5 homeodomain alter DNA-binding affinity. Reduced affinity has been attributed to structural changes at specific residues that change interactions with the major groove of DNA. 21, 24 Although I184 does not interact directly with DNA strands, molecular modeling predicted that the I184M substitution alters topographical and electrostatic characteristics of this site and could secondarily result in reduced DNA-binding affinity. The murine variant I183P, equivalent to the human 184 position (I184P), retains its ability to homodimerize but is nonetheless unable to bind DNA. 16, 27 The I184M variant found in family DO showed ≈10-fold reduced monomeric DNA binding. It is important to stress that the I184P mutation is not found in humans but was generated as a potential dominantnegative protein based on proline substitutions occurring at an equivalent position in other homeodomain proteins. Its overexpression in a mouse transgenic model led to rapid-onset DCM. 16 Collectively, our data point to helices 2 and 3, and position 184 in particular, as a focus for DCM-causative mutations with a graded Figure 6 . NKX2-5 protein levels are regulated by the Ubiquitin-proteasome system (UPS). A, Protein levels in transfected COS-7 cells were evaluated by Western blot before and after treatment with the specific proteasome inhibitor Lactacystin. Wild-type (WT) NKX2-5 levels were increased by 3.1-fold (**P<0.01; Student t test, Prism Software) on UPS inhibition. I184M NKX2-5 levels were unchanged (1.1-fold), indicating that the mutant had decreased proteasome degradation before the drug is added. Effective inhibition of the UPS was confirmed by increased CYCLIN D1 levels; α-TUBULIN was used as a loading control. B and C, Immunoprecipitation to detect poly-ubiquitylated NKX2-5 conjugates. FLAG antibody was used to pull down tagged NKX2-5 protein, whereas Western blotting has performed using anti-hemagglutinin antibodies that detected tagged Ubiquitin. Similar amounts of input NKX2-5 were confirmed using an anti-NKX2-5 antibody (bottom). D, In vitro ubiquitylation kinetics assay for WT, I184M, I184P, and Y191C NKX2-5 variants confirmed that these mutations did not impair ubiquitylation.
severity of functional effects, depending on both the position and nature of the amino acid substitution.
Transcriptional Activation Defects in the Pathogenesis of DCM
During embryonic development, NKX2-5 is essential for activation and maintenance of the cardiac regulatory network. NKX2-5 mutants have cardiomyocyte specification and maturation deeply compromised, resulting in death.
33 NKX2-5 is also essential for postnatal maturation and homeostasis of cardiomyocytes and the conduction system. [7] [8] [9] 16, 17, 19, 34 Transcriptional defects could result in primary developmental defects of the myocardial wall and altered growth and survival responses to the mechanical stresses of repetitive contraction and hemodynamic load throughout adult life. Indeed, in individuals with CHD-causing NKX2-5 mutations, altered intracardiac blood flow could contribute to the development of contractile dysfunction with aging. However, it is notable that the family DO proband developed DCM in the absence of CHD and in other family members occurred after repair of structural malformations in childhood. A link between transcription factor mutations and adult cardiac functional deficit has been highlighted by the discovery of mutations in the transcriptional coactivators EYA4 35 and T-box factor TBX20 19 in families with DCM. Taken together, our data suggest that mutations in NKX2-5 and other transcription factors should also be considered to have a major role in the pathogenesis of adult-onset familial DCM.
NKX2-5 Homeodomain Mutations Alter UPSMediated Degradation
The UPS has been implicated in the quality control and degradation of several cardiac proteins. 29 We determined that NKX2-5 is also a target for ubiquitylation and suggests that high levels of I184M NKX2-5 protein may result from interference with UPSmediated degradation downstream of the ubiquitylation event, as WT and I184M NKX2-5 proteins are ubiquitylated to a similar extent. It is clear that factors other than ubiquitylation, such as protein misfolding, alterations in the pattern of ubiquitylated residues, impaired recognition of mutant proteins by the 19S proteasome, or reduced proteolytic activity of the 20S proteasome, must be operative for I184M and other NKX2-5 homeodomain mutants. Altered UPS activity may contribute to cardiac dysfunction because of a variety of causes. 29, [36] [37] [38] [39] [40] For example, truncated cardiac myosin-binding protein C mutants that cause familial hypertrophic cardiomyopathy are preferentially targeted by the UPS and rapidly degraded, 38 whereas extensively misfolded proteins associated with DCM-causing mutations in cardiac actin are resistant to proteasomal degradation. 39 Mutant proteins can directly promote cytoplasmic aggregate formation and have nonspecific effects because of progressive overloading of proteasomal proteolytic capacity with subsequent accumulation of downstream protein targets. 41 Protein aggregation is thought to underlie contractile dysfunction in desmin 36 and αβ-crystallin transgenic mice 37 and has been observed in human myopathic hearts. 40 A mutant form of the cardiac trascription factor TBX1 bearing a poly-alanine stretch elongation found in a patient with tetralogy of Fallot showed nuclear and cytoplasmic aggregates in transfected cells. 42 It is not clear, however, whether NKX2-5 mutations inhibit the UPS via protein aggregation.
Interdependence of UPS Defects and Transcriptional Activation
Activation and degradation of transcription factors are closely linked, 30, 31 and the sequences that specify activation domains overlap with those that signal proteolysis. 43 Mandatory degradation of active transcriptional complexes allows transcriptional control over time in a binary fashion. Hence, although the mechanism underlying I184M pathogenesis is currently not fully elucidated, functional characteristics of NKX2-5 within transcriptional complexes may provide a critical clue as to why UPS-mediated NKX2-5 degradation is disrupted in certain homeodomain mutants. This notion is supported by our findings that the truncation mutant NKX2-5ΔC, normally more active, when combined with the I184P mutation, showed additionally elevated stability. Disrupted NKX2-5 UPS-mediated turnover may contribute to, or be reflective of, NKX2-5-related cardiomyopathies. Nevertheless, it distinguishes a subclass of NKX2-5 mutations, and our data on familial I184M mutation combined with the rapid-onset DCM seen in I184P transgenic mice 16 collectively suggest that this subclass may be causative for DCM with graded severity.
Complex Mechanism Underlies the Development of Cardiac Dysfunctions
Our work demonstrates that there are 2 different aspects associated with NKX2-5 mutations at I184 residues that may play interdependent roles in cardiac dysfunction: (1) isoleucine changes to methionine or proline at residue 184 lead to profound differences in NKX2-5 transcription activity; and (2) a consistent increase in protein levels, observed in both mutations at I184 and others located in helices 2 and 3 of the homeodomain. Levels of NKX2-5 protein may influence the dominant-negative activity of mutations, the expression of target genes that can be accessed by mutant protein via cofactor interactions, or the expression of offtargets that may contribute to pathology.
Another important aspect of human NKX2-5 mutations is that patients bearing these changes usually develop progressive CDs, 10, 11, 13 reproduced in mouse models. Complete postnatal ablation of NKX2-5 leads to progressive loss of cells of the cardiac conduction system concomitant with the development of cardiac arrhythmias. 8 However, it is important to understand how these observations in a full ablation model actually correlate to CDs in patients with heterozygous NKX2-5 point mutations. Impairment of transcriptional activation of target genes, such as Nppa, protein accumulation and UPS dysfunction, and differential cofactor interactions, might all play important roles in these cases. Ultimately, it remains to be seen how molecular disturbances detected in vitro might reflect on physiological function in whole organisms, where multiple levels of network regulatory control exist.
